Stock listing

TPEx:6876 Launxp Biomedical Co., Ltd. (朗齊生醫*) 股價

Follow Launxp Biomedical Co., Ltd. into a list and get an email when it puts out news.

Share price · TPEX:6876

$12.00 TWD -2.05 (-14.6%)

Close on Nov 20, 2026

This year -48.8% · daily closes, Dec 1, 2025 – Nov 20, 2026, adjusted for splits
Day range
$11.85 – $13.85 TWDNov 20, 2026
Volume
172,619 sharesNov 20, 2026
Market cap
$846.3M TWDAt the close on Nov 20, 2026 · price × 70.53M shares outstanding
Traded on an average day
$2.96M TWDMedian day 119,110 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Launxp Biomedical Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6876 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$12.00-2.05-14.6%$13.85$13.85$11.85172,619
$14.05+0.45+3.3%$13.60$14.20$13.25157,339
$13.600.000.0%$13.75$13.75$13.25156,531
$13.60-0.40-2.9%$14.00$14.00$13.5060,963
$14.00-0.05-0.4%$14.05$14.05$13.5076,782
$14.050.000.0%$14.25$14.25$13.65102,715
$14.05+0.05+0.4%$14.00$14.25$13.65124,168
$14.000.000.0%$14.00$14.00$12.85114,720
$14.00+1.40+11.1%$12.10$14.30$12.10864,804
$12.60-0.70-5.3%$13.30$13.30$12.15112,558
$13.300.000.0%$13.30$13.35$13.20265,091
$13.30-0.10-0.7%$13.40$13.60$12.90272,937
$13.40-0.75-5.3%$14.10$14.15$12.95109,126
$14.15+0.20+1.4%$13.95$14.20$12.25528,588
$13.95-0.05-0.4%$13.95$13.95$13.557,016
$14.00-0.10-0.7%$14.10$14.10$13.4516,413
$14.10+0.20+1.4%$14.05$14.10$13.9047,317
$13.90-0.05-0.4%$14.05$14.20$13.9089,751
$13.95-0.10-0.7%$13.95$13.95$13.950
$14.05-0.45-3.1%$14.40$14.45$13.9587,306
$14.500.000.0%$14.00$14.70$14.0077,376
$14.50+0.50+3.6%$13.95$14.50$13.9562,140
$14.00-0.95-6.4%$15.05$15.05$13.95256,085
$14.95-0.10-0.7%$15.05$15.05$14.9033,753
$15.05-0.20-1.3%$15.25$15.25$14.95142,743
$15.250.000.0%$15.25$15.50$14.90200,904
$15.250.000.0%$15.20$15.75$14.60114,073
$15.25+0.05+0.3%$15.40$15.40$15.0048,846
$15.20+0.10+0.7%$15.35$15.55$15.0549,603
$15.10-0.80-5.0%$16.05$16.05$14.95274,943
$15.90+0.05+0.3%$15.90$16.20$15.5029,618
$15.85-0.10-0.6%$15.95$15.95$15.25231,510
$15.95+0.15+0.9%$15.45$16.00$15.4091,317
$15.800.000.0%$15.50$16.00$15.45111,792
$15.80-1.10-6.5%$17.05$17.05$15.50288,264
$16.90-0.45-2.6%$17.40$17.40$16.90107,446
$17.35+0.15+0.9%$17.30$17.50$17.00110,108
$17.20+0.50+3.0%$17.00$18.10$16.65408,913
$16.70+0.70+4.4%$15.55$17.45$15.55317,530
$16.00+1.55+10.7%$14.70$16.05$14.70191,692
$14.45+0.05+0.3%$14.55$14.55$14.2562,953
$14.40-0.15-1.0%$14.55$14.55$13.50100,482
$14.55+0.05+0.3%$14.50$14.55$13.9512,755
$14.50-0.55-3.7%$15.05$15.05$13.35193,612
$15.05-0.35-2.3%$15.50$16.30$14.50282,137
$15.40-1.45-8.6%$17.35$17.35$13.95687,139
$16.85-0.55-3.2%$18.00$18.25$16.55673,174
$17.40+1.75+11.2%$15.80$18.35$15.401,170,669
$15.65+1.45+10.2%$15.30$16.10$14.15691,985
$14.20+2.15+17.8%$11.95$14.20$11.95217,550
$12.05-0.15-1.2%$12.15$12.25$11.90139,310
$12.20+0.20+1.7%$11.90$12.25$11.8542,914
$12.00-0.10-0.8%$12.30$12.30$11.70118,234
$12.10+0.30+2.5%$11.60$12.10$11.4091,513
$11.80-0.25-2.1%$12.05$12.05$11.40163,306
$12.05+0.15+1.3%$11.85$12.05$11.6063,118
$11.90-0.15-1.2%$12.05$12.05$11.50171,807
$12.050.000.0%$11.55$12.05$11.5540,275
$12.05-0.10-0.8%$12.15$12.15$11.75133,293
$12.15+0.05+0.4%$11.90$12.30$11.50166,901
$12.10-0.35-2.8%$12.20$12.45$11.80549,441
$12.45-0.05-0.4%$12.05$12.45$11.90119,985
Ticker
TPEx:6876
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

Launxp Biomedical Co., Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
Decks
2 decks · latest Mar 18, 2026

Valuation

Price/book 2.3× against a median of 1.6×: 8th lowest of 11 Biotechnology companies shown. balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$391.1M TWD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
2.3×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Launxp Biomedical Co., Ltd. · TPEX:6876US$25.67MUS$11.86Mn/an/an/a2.3×n/a0.0×n/a
Edesa Biotech, Inc. · NASDAQ:EDSAUS$27.02MUS$16.72Mn/an/an/a3.1×n/a0.0×0.47
Amplia Therapeutics Ltd. · ASX:ATXUS$26.84MUS$8.63Mn/an/an/a1.0×n/a0.0×n/a
Nasus Pharma Ltd. · AMEX:NSRXUS$26.82MUS$15.11Mn/an/an/a2.4×n/a0.0×0.99
Telomir Pharmaceuticals, Inc. · NASDAQ:TELOUS$26.82MUS$22.30Mn/an/an/a6.1×n/a0.0×1.74
BriaCell Therapeutics Corp · TSX:BCTUS$26.79MUS$6.25Mn/an/an/a1.7×n/a0.0×1.07
Alterity Therapeutics Ltd. · ASX:ATHUS$26.76MUS$2.18Mn/an/an/a0.9×n/a0.0×n/a
EyePoint, Inc. · NASDAQ:EYPTUS$26.65M−US$72.44Mn/a−28.1×n/a0.3×n/a0.2×1.36
Aprogen, Inc · KRX:007460US$26.64MUS$21.31Mn/a0.2×n/a0.6×−60.1%0.6×n/a
PolTREG Spolka Akcyjna · GPW:PTGUS$26.09MUS$22.35Mn/a378×n/a2.2×n/a0.1×n/a
INmune Bio Inc. · NASDAQ:INMBUS$25.60MUS$10.48Mn/an/an/a1.4×n/a0.1×2.63
Median of the othersUS$26.77MUS$12.80M0.2×1.6×−60.1%0.0×1.22

Team and board

Officers

OfficerRole
Aileen HsuChief Financial Officer
John ChenPresident

Board

DirectorRole
Jeffrey WangChairman of the Board
Chia-Chung ChanIndependent Director
Chu-yuan ChuIndependent Director
John ChenPresident
Kuo-Bin LinIndependent Director
Li-yun ChenDirector
Rui-xing ChenDirector
Simon HuangDirector
Wen-Sun TsengDirector

Decks

DeckKindSlidesDate
Earnings Presentation (March 2026)Earnings37 slidesMar 18, 2026
Investor Presentation (October 2024)Investor deck50 slidesOctober 2024

Open Decks

Financials

Annual, in TWD

Income statement

LineFY2024FY2023FY2022FY2021
Revenue2.48M11.0K00
Cost of revenue199.0K000
Gross profit2.29M11.0K00
Research and development37.6M43.7M19.7M15.1M
Selling, general and administrative46.9M37.4M23.9M8.18M
Operating income-82.3M-81.0M-43.6M-34.8M
Depreciation and amortization2.40M2.41M2.35M1.60M
EBITDA-79.9M-78.6M-41.3M-33.2M
Interest expense42.0K167.0K195.0K60.0K
Income before tax-82.1M-80.9M-43.6M-34.7M
Net income-82.6M-80.9M-43.6M-34.7M
Earnings per share, basic-2.55-2.51-1.35-1.08

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents98.4M179.7M15.2M34.1M
Short-term investments27.0M
Receivables09.00K0
Current assets104.9M185.5M24.2M64.2M
Total assets123.9M206.5M32.4M73.9M
Accounts payable2.38M1.94M411.0K0
Current liabilities13.9M21.5M7.58M5.17M
Total liabilities15.0M23.2M10.2M8.65M
Shareholders' equity108.9M183.3M22.2M65.2M
Shares outstanding48.0M32.4M32.2M32.2M32.2M

Cash flow

LineFY2024FY2023FY2022FY2021
Cash from operations-76.7M-59.1M-44.2M-29.0M
Capital spending-316.0K-3.31M-804.0K-4.24M
Free cash flow-77.0M-62.5M-45.0M-33.2M
Change in cash-81.4M164.5M-18.9M2.20M

Open Financials

Cap table

Built by 6ix from Launxp Biomedical Co., Ltd.’s releases

Common shares
70,528,543
Fully diluted
70,528,543

Fully diluted

LineShares
Common shares70,528,543

Share count over time

CountShares
Nov 22, 202670,528,543

Open Cap table

Shareholders

HolderSharesOf the companyAs of
曾文尚708K1.0%Oct 31, 2026
成瀚投資股份有限公司700K0.99%Oct 31, 2026
王繼賢500K0.71%Oct 31, 2026
(月太)湛生物科技股份有限公司309K0.44%Oct 31, 2026
陳丘紘262K0.37%Oct 31, 2026
楊彩秀61,2000.09%Oct 31, 2026
陳瑞杏50,0000.07%Oct 31, 2026
徐婕云38,0000.05%Oct 31, 2026
林國彬00.00%Oct 31, 2026
詹家昌00.00%Oct 31, 2026
All 13 holders
HolderSharesOf the companyAs of
朱竹元00.00%Oct 31, 2026
陳立雲00.00%Oct 31, 2026
黃濟鴻00.00%Oct 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Aileen HsuChief Financial Officer · Since at least Nov 5, 2026
Chia-Chung ChanIndependent Director · Since at least Nov 5, 2026
Chu-yuan ChuIndependent Director · Since at least Nov 5, 2026
Jeffrey WangChairman of the Board · Since at least Nov 5, 2026
John ChenPresident · Since at least Nov 5, 2026
Kuo-Bin LinIndependent Director · Since at least Nov 5, 2026
Li-yun ChenDirector · Since at least Nov 5, 2026
Rui-xing ChenDirector · Since at least Nov 5, 2026
Simon HuangDirector · Since at least Nov 5, 2026
Wen-Sun TsengDirector · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Launxp Biomedical Co., Ltd.